View in EDS

Machine Learning to Predict Faricimab Treatment Outcome in Neovascular Age-Related Macular Degeneration.

Saved in:
Bibliographic Details
Title: Machine Learning to Predict Faricimab Treatment Outcome in Neovascular Age-Related Macular Degeneration.
Authors: Kikuchi Y; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California.; Department of Industrial Engineering and Operations Research, University of California, Berkeley, Berkeley, California., Kawczynski MG; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California., Anegondi N; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California.; Clinical Imaging Group, Genentech, Inc., South San Francisco, California., Neubert A; Data & Analytics, Roche Pharma Research and Early Development, Basel, Switzerland., Dai J; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California., Ferrara D; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California., Quezada-Ruiz C; Clinical Science, Genentech, Inc., South San Francisco, California.; Department of Ophthalmology, Clínica de Ojos Garza Viejo, San Pedro Garza, Garcia, Nuevo Leon, Mexico.
Source: Ophthalmology science [Ophthalmol Sci] 2023 Aug 18; Vol. 4 (2), pp. 100385. Date of Electronic Publication: 2023 Aug 18 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier, B.V Country of Publication: Netherlands NLM ID: 9918230896206676 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-9145 (Electronic) Linking ISSN: 26669145 NLM ISO Abbreviation: Ophthalmol Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37868796
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Machine Learning to Predict Faricimab Treatment Outcome in Neovascular Age-Related Macular Degeneration.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kikuchi+Y%22">Kikuchi Y</searchLink>; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California.; Department of Industrial Engineering and Operations Research, University of California, Berkeley, Berkeley, California.<br /><searchLink fieldCode="AU" term="%22Kawczynski+MG%22">Kawczynski MG</searchLink>; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Anegondi+N%22">Anegondi N</searchLink>; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California.; Clinical Imaging Group, Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Neubert+A%22">Neubert A</searchLink>; Data & Analytics, Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dai+J%22">Dai J</searchLink>; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Ferrara+D%22">Ferrara D</searchLink>; Roche Personalized Healthcare Program, Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Quezada-Ruiz+C%22">Quezada-Ruiz C</searchLink>; Clinical Science, Genentech, Inc., South San Francisco, California.; Department of Ophthalmology, Clínica de Ojos Garza Viejo, San Pedro Garza, Garcia, Nuevo Leon, Mexico.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918230896206676%22">Ophthalmology science</searchLink> [Ophthalmol Sci] 2023 Aug 18; Vol. 4 (2), pp. 100385. <i>Date of Electronic Publication: </i>2023 Aug 18 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+B%2EV%22">Elsevier, B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9918230896206676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-9145 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226669145%22">26669145 </searchLink><i>NLM ISO Abbreviation: </i>Ophthalmol Sci <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37868796
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.xops.2023.100385
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100385
    Titles:
      – TitleFull: Machine Learning to Predict Faricimab Treatment Outcome in Neovascular Age-Related Macular Degeneration.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kikuchi Y
      – PersonEntity:
          Name:
            NameFull: Kawczynski MG
      – PersonEntity:
          Name:
            NameFull: Anegondi N
      – PersonEntity:
          Name:
            NameFull: Neubert A
      – PersonEntity:
          Name:
            NameFull: Dai J
      – PersonEntity:
          Name:
            NameFull: Ferrara D
      – PersonEntity:
          Name:
            NameFull: Quezada-Ruiz C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 08
              Text: 2023 Aug 18
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2666-9145
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Ophthalmology science
              Type: main
ResultId 1